Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BILIBILI-W
09626
5
ALI HEALTH
00241
HK Stock MarketDetailed Quotes
CH ENV TECH&BIO (01237)
- 0.940
- -0.030-3.09%
Market Closed Feb 12 15:17 CST
90.27MMarket Cap6.10P/E (TTM)
0.000High0.000Low0Volume0.940Open0.970Prev Close0.00Turnover0.00%Turnover Ratio27.65P/E (Static)96.04MShares1.50052wk High0.09P/B90.27MFloat Cap0.28052wk Low--Dividend TTM96.04MShs Float74.257Historical High--Dividend LFY0.00%Range %0.260Historical Low--Avg Price10000Lot Size--Div Yield TTM--Div Yield LFY
CH ENV TECH&BIO (01237) News
China Environmental Technology Clarifies Share Award Scheme Details
China Environmental Technology Grants 9.6 Million Share Awards to Employees
Sinobiological (01237.HK) Granted a Total of 9.6 Million Reward Shares
Gelonghui December 5th丨Zhongke Biotech (01237.HK) announced that on December 1, 2025, the company granted a total of 9.6 million award shares to 11 grantees under the terms of the 2025 Share Award Plan, subject to the acceptance by the grantees for it to take effect. Each share award granted to the grantees represents the right to receive one share on its vesting date.
Zhitong HK Stock Investment Diary | October 16
Hong Kong Stock Investment Diary | October 16, 2025
Zhitong HK Stock Investment Diary | October 13
HK Stock Investment Log | October 13, 2025
CH ENV TECH&BIO: Interim Report 2025
Zhongke Biological (01237.HK) achieved a turnaround to profit in the first half of the year, reaching HKD 8.8 million.
On August 29, Gelonghui reported that Zhongke Biological (01237.HK) announced its interim results for the first half of 2025, with the group's revenue slightly increasing by 7.0% compared to the same period last year, reaching RMB 199.95 million. During the period, the group recorded a gross profit margin of 12.9% (first half of 2024: 7.2%). The gross profit for the period was RMB 15.7 million (first half of 2024: RMB 13.4 million). The group recorded a profit of approximately RMB 8.8 million during the period (first half of 2024: a loss of RMB 1.7 million). The group's core business segments include the production and sale of wooden products, as well as
CH ENV TECH&BIO: 2025 INTERIM RESULTS ANNOUNCEMENT
In its profit alert, Zhongke Biotechnology (01237.HK) has turned a profit in the interim period, expecting a net profit of approximately 9 million yuan.
Zhongke Biological (01237.HK) has issued a profit warning, expecting to record a net profit attributable to shareholders of approximately 9 million yuan in the first half of the year, compared to a net loss of 17 million yuan in the same period last year. The group stated that it achieved a turnaround from loss to profit primarily due to the recognition of foreign exchange gains of approximately 16 million yuan during the period.
CH ENV TECH&BIO: PROFIT WARNING
America's Most Popular Furniture Brands May Get More New Tariffs -- WSJ
China Environmental Technology and Bioenergy Holdings to Announce Interim Results
Zhongke Biological (01237.HK) will hold a board meeting on August 29 to approve its interim results.
Gelonghui, August 19 – Zhongke Biological (01237.HK) announced that the company will hold a board meeting on August 29, 2025, to review and approve the group's interim results for the six months ending June 30, 2025, and their publication, as well as the declaration of an interim dividend (if any).
CH ENV TECH&BIO: SUPPLEMENTAL ANNOUNCEMENTIN RELATION TO THE 2024 ANNUAL REPORT
Express News | At the midday close of the Hong Kong stock market, the Hang Seng Index rose by 0.49%, and the Hang Seng Tech Index increased by 0.93%. CH ENV TECH&BIO surged over 40%.
CH ENV TECH&BIO (01237.HK) has issued 3.9 million shares under the company's share award scheme.
Gelonghui, July 30th | CH ENV TECH&BIO (01237.HK) announced that on July 30, 2025, 3.9 million shares of the company were issued under the company's share incentive plan.
Express News | ST Ningke: Expected net income loss of RMB 160 million to RMB 200 million in the first half of 2025.
CH ENV TECH&BIO: 2024 ANNUAL REPORT
CH ENV TECH&BIO: ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
In the announcement, CH ENV TECH&BIO (01237.HK) has reversed 8.8 million yuan, forecasting a turnaround in annual performance.
CH ENV TECH&BIO (01237.HK) announces a profit alert, expecting a net profit of about 3 million RMB in 2024, compared to a loss of 2.4 million RMB in the previous year. The turnaround is mainly due to the reversal of excess provisions for income tax expenses of about 8.8 million RMB from the previous year.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
New Consumption Stocks New Consumption Stocks
New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations. New Consumption Stocks refer to emerging consumer companies that leverage innovative business models, digital technology, and personalized products to meet the emotional value and upgraded lifestyle demands of younger generations.
View More
Hot Topics Hot Topics
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde
年頭旺到年尾
Aug 21, 2025 06:11
Are you foolish? What's the point of knowing your mistakes?
牛牛課堂
Sep 12, 2025 17:29
[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?